Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 39, Issue Suppl. 3
October 2016 2017
Issue Cover
ISSN 2296-5270
EISSN 2296-5262
In this Issue
Search within issue

Oncology Research and Treatment 2016, Vol. 39, Suppl. 3

All Issues
Paclitaxel/Ramucirumab vs. Paclitaxel in 2nd-line therapy of advanced esophageal squamous cell carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial
Effektive Therapieoption: Pegcetacoplan bei PNH
r/r LBCL: CAR-T-Zelltherapie im Behandlungsalltag
Resektabilität bei NSCLC III: Schlüssel zur Therapie
  • Online ISSN 2296-5262
  • Print ISSN 2296-5270
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal